Literature DB >> 6712322

Relation of doubling time of plasma calcitonin levels to prognosis and recurrence of medullary thyroid carcinoma.

A Miyauchi, T Onishi, S Morimoto, S Takai, F Matsuzuka, K Kuma, M Maeda, Y Kumahara.   

Abstract

Plasma calcitonin (CT) levels were measured serially in 54 patients surgically treated for medullary thyroid carcinoma. Patients with postoperative basal CT levels higher than 1 ng/ml measured within 1 month after surgery had a higher recurrence rate than those with lower CT levels (p less than 0.002). Patients with postoperative basal CT levels higher than 2 ng/ml had a lower survival rate than those with lower CT levels (p less than 0.01). However, preoperative basal CT levels had no significant correlation with life expectancy or recurrence during the present observation period. Serial measurements in 23 patients with elevated postoperative CT levels showed exponential increases in basal CT levels in 19 patients (p less than 0.05 in nine patients, 0.05 less than p less than 0.1 in four patients) and slight decreases in four (p less than 0.05 in one patient). Doubling time of CT levels calculated from the regression line in each patient showed the highest correlation with 3-year survival, recurrence within 5 years, and time interval between surgery and clinical recurrence of the tumor, allowing quantitative prediction of the prognosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6712322      PMCID: PMC1353366          DOI: 10.1097/00000658-198404000-00014

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  24 in total

1.  C-cell hyperplasia preceding medullary thyroid carcinoma.

Authors:  H J Wolfe; K E Melvin; S J Cervi-Skinner; A A Saadi; J F Juliar; C E Jackson; A H Tashjian
Journal:  N Engl J Med       Date:  1973-08-30       Impact factor: 91.245

Review 2.  Studies in familial (medullary) thyroid carcinoma.

Authors:  K E Melvin; A H Tashjian; H H Miller
Journal:  Recent Prog Horm Res       Date:  1972

3.  Detection of medullary thyroid cancer by calcitonin assay in families.

Authors:  C E Jackson; A H Tashjian; M A Block
Journal:  Ann Intern Med       Date:  1973-06       Impact factor: 25.391

4.  Growth of seventy-eight recurrent mammary cancers. Quantitative study.

Authors:  E Philippe; Y Le Gal
Journal:  Cancer       Date:  1968-03       Impact factor: 6.860

5.  Radioimmunoassay for calcitonin in medullary thyroid carcinoma.

Authors:  L J Deftos
Journal:  JAMA       Date:  1974-01-28       Impact factor: 56.272

6.  The cross rates of growth of human mammary carcinoma.

Authors:  S Kusama; J S Spratt; W L Donegan; F R Watson; C Cunningham
Journal:  Cancer       Date:  1972-08       Impact factor: 6.860

7.  Immunoassay of human calcitonin.

Authors:  A H Tashijan; B G Howland; K E Melvin; C S Hill
Journal:  N Engl J Med       Date:  1970-10-22       Impact factor: 91.245

8.  Medullary carcinoma of the thyroid gland.

Authors:  G C Chong; O H Beahrs; G W Sizemore; L H Woolner
Journal:  Cancer       Date:  1975-03       Impact factor: 6.860

9.  Medullary carcinoma of the thyroid in Norway. Clinical course and endocrinological aspects.

Authors:  T Normann; K M Gautvik; J V Johannessen; I O Brennhovd
Journal:  Acta Endocrinol (Copenh)       Date:  1976-09

10.  The early diagnosis of medullary carcinoma of the thyroid gland in patients with multiple endocrine neoplasia type II.

Authors:  S A Wells; D A Ontjes; C W Cooper; J F Hennessy; G J Ellis; H T McPherson; D C Sabiston
Journal:  Ann Surg       Date:  1975-10       Impact factor: 12.969

View more
  32 in total

1.  Adjuvant external beam radiation for medullary thyroid carcinoma.

Authors:  Steve R Martinez; Shannon H Beal; Allen Chen; Steven L Chen; Philip D Schneider
Journal:  J Surg Oncol       Date:  2010-08-01       Impact factor: 3.454

2.  Ultrastructural study of poorly differentiated medullary carcinoma of the thyroid.

Authors:  K Kakudo; A Miyauchi; S Katayama; K Watanabe
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

3.  Immunohistochemical study of medullary thyroid carcinoma: relationship of clinical features to prognostic factors in 36 patients.

Authors:  H Takami; T Bessho; T Kameya; T Mimura; K Ito; O Abe; Y Hosoda; J Shikata
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

4.  99mTc(V)-dimercaptosuccinic acid scintigraphy for medullary thyroid carcinoma.

Authors:  A Miyauchi; K Endo; H Ohta; K Torizuka; F Matsuzuka; A Kobayashi; K Kuma; M Maeda
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

Review 5.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

Review 6.  Calcitonin as a biomarker of C cell disease: recent achievements and current challenges.

Authors:  Giuseppe Costante; Domenico Meringolo
Journal:  Endocrine       Date:  2020-01-10       Impact factor: 3.633

7.  MiR-375 and YAP1 expression profiling in medullary thyroid carcinoma and their correlation with clinical-pathological features and outcome.

Authors:  Francesca Galuppini; Loris Bertazza; Susi Barollo; Elisabetta Cavedon; Massimo Rugge; Vincenza Guzzardo; Diana Sacchi; Sara Watutantrige-Fernando; Federica Vianello; Caterina Mian; Gianmaria Pennelli
Journal:  Virchows Arch       Date:  2017-08-31       Impact factor: 4.064

8.  Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Differentiated Thyroid Carcinoma Having Distant Metastasis: A Comparison With Thyroglobulin-doubling Rate and Tumor Volume-doubling Rate.

Authors:  Yasuhiro Ito; Naoyoshi Onoda; Minoru Kihara; Akihiro Miya; Akira Miyauchi
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

Review 9.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

10.  The prognostic value of tumor markers doubling times in medullary thyroid carcinoma - preliminary report.

Authors:  Tomasz Gawlik; Andrea d'Amico; Sylwia Szpak-Ulczok; Aleksander Skoczylas; Elżbieta Gubała; Anna Chorąży; Kamil Gorczewski; Jan Włoch; Barbara Jarząb
Journal:  Thyroid Res       Date:  2010-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.